Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 3
1997 1
1999 3
2000 2
2002 3
2007 1
2008 2
2010 3
2011 3
2012 6
2013 7
2014 6
2015 2
2016 2
2017 8
2018 3
2019 6
2020 6
2021 4
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

59 results
Results by year
Filters applied: . Clear all
Page 1
[Multiple bronchial varices].
Otsuka T, Okishio K, Kawaguchi T, Fujii T, Syoji S, Kanazawa H, Kudoh S, Hirata K, Kurihara N. Otsuka T, et al. Among authors: okishio k. Nihon Kyobu Shikkan Gakkai Zasshi. 1996 Mar;34(3):327-30. Nihon Kyobu Shikkan Gakkai Zasshi. 1996. PMID: 8778474 Review. Japanese.
Phase 1b study of ramucirumab in combination with erlotinib or osimertinib for untreated EGFR-mutated non-small cell lung cancer patients with asymptomatic brain metastases.
Kaneda H, Sawa K, Daga H, Okada A, Nakatani Y, Atagi S, Okishio K, Tani Y, Matsumoto Y, Ogawa K, Nakahama K, Izumi M, Mitsuoka S, Kawaguchi T. Kaneda H, et al. Among authors: okishio k. Invest New Drugs. 2021 Dec;39(6):1598-1603. doi: 10.1007/s10637-021-01147-w. Epub 2021 Jul 2. Invest New Drugs. 2021. PMID: 34215931 Clinical Trial.
Phase 2 study of bevacizumab plus carboplatin/nab-paclitaxel followed by bevacizumab plus nab-paclitaxel for non-squamous non-small cell lung cancer with malignant pleural effusion.
Tamiya M, Tamiya A, Suzuki H, Taniguchi Y, Katayama K, Minomo S, Nakao K, Takeuchi N, Matsuda Y, Naito Y, Shiroyama T, Okamoto N, Okishio K, Kumagai T, Atagi S, Imamura F, Hirashima T. Tamiya M, et al. Among authors: okishio k. Invest New Drugs. 2021 Aug;39(4):1106-1112. doi: 10.1007/s10637-021-01076-8. Epub 2021 Feb 5. Invest New Drugs. 2021. PMID: 33544282 Clinical Trial.
Nivolumab treatment of elderly Japanese patients with non-small cell lung cancer: subanalysis of a real-world retrospective observational study (CA209-9CR).
Okishio K, Morita R, Shimizu J, Saito H, Sakai H, Kim YH, Hataji O, Yomota M, Nishio M, Aoe K, Kanai O, Kumagai T, Kibata K, Tsukamoto H, Oizumi S, Fujimoto D, Tanaka H, Mizuno K, Masuda T, Kozuki T, Haku T, Suzuki H, Okamoto I, Hoshiyama H, Yada N, Ohe Y. Okishio K, et al. ESMO Open. 2020 Jul;5(4):e000656. doi: 10.1136/esmoopen-2019-000656. ESMO Open. 2020. PMID: 32690620 Free PMC article.
Real-world effectiveness and safety of nivolumab in patients with non-small cell lung cancer: A multicenter retrospective observational study in Japan.
Morita R, Okishio K, Shimizu J, Saito H, Sakai H, Kim YH, Hataji O, Yomota M, Nishio M, Aoe K, Kanai O, Kumagai T, Kibata K, Tsukamoto H, Oizumi S, Fujimoto D, Tanaka H, Mizuno K, Masuda T, Kozuki T, Haku T, Suzuki H, Okamoto I, Hoshiyama H, Ueda J, Ohe Y. Morita R, et al. Among authors: okishio k. Lung Cancer. 2020 Feb;140:8-18. doi: 10.1016/j.lungcan.2019.11.014. Epub 2019 Nov 20. Lung Cancer. 2020. PMID: 31838169 Free article.
59 results